中国实用外科杂志2018，Vol.38Issue(1)：65-67,3.DOI:10.19538/j.cjps.issn1005-2208.2018.01.13
再谈经肛全直肠系膜切除的进展、争议及前景
Futher discussion on the progress and controversy and prospect of the procedure of transanal total mesorectal excision
摘要
Abstract
In recent years,the most controversial progress rectal surgery is more than transanal total mesorectal excision (TaTME).Compared with the traditional TME,the difficulty and risk of TaTME is greater,the learning curve is longer and the surgical indication is narrower;however,the advantage of TaTME is also very obvious,the implementation of higher quality TME procedure can be got in low rectal cancer patients even with "difficult pelvic".Others advantages include the distal margin of more ensure,less surgical trauma,even the natural orifice transluminal endoscopic surgery (NOTES) concept.In September 2017,"Consensus and Surgical Guidelines for Transanal Total Mesorectal Excision in Rectal Cancer (Version.2017)" was published,which play an important role in standardizing the indications,operation and training of TaTME procedure.It arouses the attention of domestic counterparts and the attention of international counterparts.However,the domestic TaTME related clinical trials are rare,especially the multicenter,national research.In the future,based upon participating in national and international TaTME clinical trials,and structured training,the surgeon can carry out TaTME standard operation.Then,high levels of Chinese TaTME clinical research results based on evidence-based medicine" evidence can be obtained,which would be the basis of "Chinese guideline of TaTME Clinical Practice".Therefore,it is foreseeable that TaTME will also go ahead in the dispute.关键词
直肠癌/全直肠系膜切除/经肛全直肠系膜切除/结构化培训/登记研究/临床试验Key words
rectal cancer/total mesorectal excision/transanal total mesorectal excision/structured training/registry study/clinical trial分类
医药卫生引用本文复制引用
张忠涛,姚宏伟..再谈经肛全直肠系膜切除的进展、争议及前景[J].中国实用外科杂志,2018,38(1):65-67,3.基金项目
国家科技支撑计划课题(No.2015BAI13B09) （No.2015BAI13B09）
北京市医院管理局临床医学发展专项基金(No.ZYLX201504) （No.ZYLX201504）
首都医科大学附属北京友谊医院科研启动基金(No.YYQDKT2016-5) （No.YYQDKT2016-5）
